Rosa & Co. announced today the contributions of Drs. Christina Friedrich, Vincent Hurez, and Maria-Luisa Ruiz to the article titled, “Quantitative systems pharmacology model-based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3- kinase inhibitors,” which was published in CPT Pharmacometrics Systems Pharmacology on December 1, 2021.
To read the article: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/psp4.12749